Episode Overview:

In our inaugural This Week in Pharmacy, we examine the economic, technological, and policy-driven forces transforming pharmacy practice and the U.S. drug supply chain. From hidden financial power structures and AI-enabled operations to federal policy shifts impacting biosimilars, this episode brings together three timely conversations that every pharmacy leader should hear.

Segment 1: The Hidden Lender in America’s Drug Supply Chain

Guests:

Building on Alec Ginsberg’s investigative article, “The Hidden Lender in America’s Drug Supply Chain,” this discussion exposes how capital flows, credit structures, and opaque financial relationships influence pharmacy viability. Ciaccia and Ginsberg break down what independent pharmacists need to understand about who truly controls leverage in the system—and why transparency matters more than ever.

 

Segment 2: How AI Is Transforming Pharmacy Operations

Guests:

Artificial intelligence is no longer theoretical in pharmacy—it’s operational. This segment explores how AI is being deployed today to improve workflow efficiency, clinical decision-making, and patient engagement, while addressing the real-world challenges of adoption.

Segment 3: Policy Watch – IRA, Trump-Era Rx Changes & Biosimilars

Guest:

In this special policy-focused feature, Dr. Daley unpacks upcoming IRA-related developments and potential Trump-era prescription drug policy changes, with a sharp focus on how they could impact biosimilars and the U.S. supply chain. The conversation highlights what pharmacists should watch closely as regulatory and political pressures continue to evolve.

 

Inside the Forces Reshaping America’s Drug Supply Chain | TWIRx   

Thanks to NimbleRx, PRISM by OvaryIT, and Sykes & Company for sponsorsing today's show